Regulatory Aspects Towards Approval of Nanomedicine

Nanomedicines have been in the forefront of pharmaceutical research in the last decades, creating new challenges for research community, industry, and regulators. There is a strong demand for the fast development of scientific and technological tools to address unmet medical needs, thus improving human health care and life quality. Tremendous advances in the biomaterials and nanotechnology fields have prompted their use as promising tools to overcome important drawbacks, mostly associated to the non-specific effects of conventional therapeutic approaches. However, the wide range of application of nanomedicines demands a profound knowledge and characterization of these complex products. Their properties need to be extensively understood to avoid unpredicted effects on patients, such as potential immune reactivity. Research policy and alliances have been bringing together scientists, regulators, industry, and, more frequently in recent years, patient representatives and patient advocacy institutions. In order to successfully enhance the development of new technologies, improved strategies for research-based corporate organizations, more integrated research tools dealing with appropriate translational requirements aiming at clinical development, and proactive regulatory policies are essential in the near future. This review focuses on the most important aspects currently recognized as key factors for the regulation of nanomedicines, discussing the efforts under development by industry and regulatory agencies to promote their translation into the market.

 

  • Nanomedicine: Prospects, Risks and Regulatory Issues
  • Current , Future Applications and Regulatory challenges
  • Research Policy and Alliances
  • Regulatory Policies
  • Regulation of Nanomedicines

Related Conference of Regulatory Aspects Towards Approval of Nanomedicine

October 02-03, 2023

20th International Conference on Pharmaceutical Chemistry

Frankfurt, Germany
October 12-13, 2023

26th World Congress on Nursing, Pharmacology and Healthcare

Budapest, Hungary
November 09-10, 2023

11th International Conference on Clinical Trials

London, UK
November 10-11, 2023

3rd World Biosimilars & Biologics Congress

Berlin, Germany
November 27-28, 2023

19th World Congress on Drug Formulation & Drug Delivery

Bangkok, Thailand
December 05-06, 2023

2nd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
February 01-02, 2024

37th World Congress on Pharmacology

Dubai, UAE
February 22-23, 2024

34th Annual European Pharma Congress

Zurich, Switzerland
April 04-05, 2024

17th European Biosimilars Congress

Madrid, Spain
April 11-12, 2024

5th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France

Regulatory Aspects Towards Approval of Nanomedicine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in